Annotation Detail for LYSMD3
Basic Information
Top
| Gene Symbol: | LYSMD3 ( DKFZp686F0735,FLJ13542 ) |
|---|
| Gene Full Name: | LysM, putative peptidoglycan-binding, domain containing 3 |
|---|
| Band: | 5q14.3 |
|---|
| Quick Links | Entrez ID:116068; OMIM: NA; Uniprot ID:LYSM3_HUMAN; ENSEMBL ID: ENSG00000176018; HGNC ID: 26969 |
|---|
| Relate to Another Database: |
SFARIGene;
denovo-db |
| Chemical ID |
Chemical Name |
Interaction |
Interaction Action |
Publication |
|---|
| D016572 |
Cyclosporine |
Cyclosporine results in increased expression of LYSMD3 mRNA | increases expression | 20106945
|
| D004041 |
Dietary Fats |
Dietary Fats results in increased expression of LYSMD3 mRNA | increases expression | 18042831
|
| C041786 |
palm oil |
palm oil results in increased expression of LYSMD3 mRNA | increases expression | 18042831
|
| C025643 |
vinclozolin |
vinclozolin affects the expression of LYSMD3 mRNA | affects expression | 19015723
|
| Disease ID |
Disease Name |
Direct Evidence |
Inference Chemical Name |
Inference Score |
Publication |
|---|
| MESH:D001008 |
Anxiety Disorders |
|
vinclozolin |
3.97 | 19015723 |
| MESH:D001161 |
Arteriosclerosis |
|
Dietary Fats |
4.45 | 15238619 |
| MESH:D001943 |
Breast Neoplasms |
|
Dietary Fats |
2.24 | 20435547 |
| MESH:D002471 |
Cell Transformation, Neoplastic |
|
Cyclosporine |
2.79 | 12371664 |
| MESH:D002779 |
Cholestasis |
|
Cyclosporine |
3.21 | 19486331 |
| MESH:D003456 |
Cryptorchidism |
|
vinclozolin |
4.85 | 14966744 |
| MESH:D050171 |
Dyslipidemias |
|
Dietary Fats |
3.73 | 18367378 |
| MESH:D005234 |
Fatty Liver |
|
Cyclosporine |
9.18 | 19224547 |
| MESH:D005234 |
Fatty Liver |
|
Dietary Fats |
9.18 | 17967931 19004024 18296743 19551842 |
| MESH:D005355 |
Fibrosis |
|
Cyclosporine |
10.63 | 12639820 12168785 |
| MESH:D005355 |
Fibrosis |
|
Dietary Fats |
10.63 | 18296743 |
| MESH:D030342 |
Genetic Diseases, Inborn |
|
vinclozolin |
5.57 | 16973722 |
| MESH:D005832 |
Genital Diseases, Male |
|
vinclozolin |
6.02 | 16417039 |
| MESH:D005885 |
Gingival Hyperplasia |
|
Cyclosporine |
4.85 | 8708960 |
| MESH:D006457 |
Hemoglobinuria, Paroxysmal |
|
Cyclosporine |
5.05 | 15720958 |
| MESH:D006937 |
Hypercholesterolemia |
|
Dietary Fats |
4.02 | 21332399 |
| MESH:D006949 |
Hyperlipidemias |
|
Dietary Fats |
4.08 | 21332399 |
| MESH:D006973 |
Hypertension |
|
Cyclosporine |
2.21 | 10903974 |
| MESH:D007248 |
Infertility, Male |
|
vinclozolin |
3.29 | 16467254 |
| MESH:D007249 |
Inflammation |
|
Dietary Fats |
2.60 | 20412841 |
| MESH:D007333 |
Insulin Resistance |
|
Dietary Fats |
3.34 | 11836018 18457598 |
| MESH:D007638 |
Keratoconjunctivitis Sicca |
|
Cyclosporine |
5.16 | 15604871 |
| MESH:D007674 |
Kidney Diseases |
|
Cyclosporine |
2.54 | 18776723 10903974 8314463 |
| MESH:D007680 |
Kidney Neoplasms |
|
Cyclosporine |
3.08 | 12371664 |
| MESH:D007984 |
Leydig Cell Tumor |
|
vinclozolin |
5.36 | 16417039 |
| MESH:D008103 |
Liver Cirrhosis |
|
Dietary Fats |
3.07 | 18296743 |
| MESH:D008664 |
Metal Metabolism, Inborn Errors |
|
Cyclosporine |
5.51 | 16801185 |
| MESH:D009402 |
Nephrosis, Lipoid |
|
Cyclosporine |
5.16 | 17954296 |
| MESH:D009404 |
Nephrotic Syndrome |
|
Cyclosporine |
3.65 | 19348381 18481113 |
| MESH:D009765 |
Obesity |
|
Dietary Fats |
2.36 | 21332399 20132043 17217161 18457598 20518802 11836018 16723640 18674790 19632207 |
| MESH:D011230 |
Precancerous Conditions |
|
Cyclosporine |
3.59 | 12371664 |
| MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
vinclozolin |
4.53 | 18220299 19015723 18042343 |
| MESH:D011469 |
Prostatic Diseases |
|
vinclozolin |
5.57 | 18220299 |
| MESH:D011472 |
Prostatitis |
|
vinclozolin |
5.57 | 18629315 |
| MESH:D011565 |
Psoriasis |
|
Cyclosporine |
2.33 | 16882103 |
| MESH:D014605 |
Uveitis |
|
Cyclosporine |
4.71 | 1336536 |
| MESH:D015430 |
Weight Gain |
|
Dietary Fats |
4.11 | 16723640 |
| MESH:D014985 |
Xerophthalmia |
|
Cyclosporine |
5.16 | 17120751 |
Related Pathway Information